1-151404931-A-C
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_015100.4(POGZ):āc.4104T>Gā(p.Thr1368=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0481 in 1,614,044 control chromosomes in the GnomAD database, including 11,357 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Synonymous variant affecting the same amino acid position (i.e. T1368T) has been classified as Likely benign.
Frequency
Consequence
NM_015100.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
POGZ | NM_015100.4 | c.4104T>G | p.Thr1368= | synonymous_variant | 19/19 | ENST00000271715.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
POGZ | ENST00000271715.7 | c.4104T>G | p.Thr1368= | synonymous_variant | 19/19 | 1 | NM_015100.4 | P3 |
Frequencies
GnomAD3 genomes AF: 0.118 AC: 17942AN: 152036Hom.: 2351 Cov.: 32
GnomAD3 exomes AF: 0.114 AC: 28715AN: 251466Hom.: 4469 AF XY: 0.0999 AC XY: 13577AN XY: 135910
GnomAD4 exome AF: 0.0408 AC: 59714AN: 1461890Hom.: 8997 Cov.: 36 AF XY: 0.0402 AC XY: 29258AN XY: 727248
GnomAD4 genome AF: 0.118 AC: 17989AN: 152154Hom.: 2360 Cov.: 32 AF XY: 0.125 AC XY: 9272AN XY: 74382
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 03, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 24, 2016 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at